Generic Name and Formulations:
Hydroquinone 2%, ethyldihydroxypropyl PABA 5%, dioxybenzone 3%, oxybenzone 2%; crm; contains sulfites.
Valeant Pharmaceuticals, Inc
Indications for SOLAQUIN:
Hyperpigmented skin conditions.
Apply and massage in twice daily; max 2 months.
Avoid eyes. Use cautiously near lips, eyes, nose. Do 24 hr patch test before use; do not use if itching, vesicle formation, or excessive inflammatory response occurs. Close patient supervision recommended. Discontinue if sensitization occurs. Asthma. Avoid sun or UV light. Pregnancy (Cat.C). Nursing mothers.
Depigmenting agent + sunscreens.
Clinical Pain Advisor Articles
- Virtual Reality May Effectively Reduce Sensory, Affective, and Cognitive Pain During Labor
- Suprazygomatic Sphenopalatine Ganglion Block May Quickly Relieve Status Migrainosus Pain
- Reducing Mortality After Overdose: Is Treatment for Opioid Use Disorder Effective?
- A Physician's Guide to Incorporating Patient Spirituality in Practice
- Low Literacy Self-Management Program for Chronic Pain May Be Effective
- Neuropathic Pain Medications
- Higher Buprenorphine Dose May Not Increase Severity of Neonatal Abstinence Syndrome
- Terms Used for Addiction May Be Associated With Explicit, Implicit Bias
- Ketamine Infusions May Be Effective for Refractory Headache
- Physical, Psychosocial Activity May Be Protective Against Development of Chronic Pain in Older Adults
- FDA Approves Minimally-Invasive, Non-Drug Therapy for Pain Management
- Chronic Migraine and Medication Overuse Headache Linked to Stress
- Set of Personality Traits May Predict Prescription Drug Use, Misuse in Young Adults
- The Opioid Crisis: District by District
- Opioid Administration, Prescribing in the ED on the Decline in Recent Years